Clinical trial
Aflibercept Injection for Treatment of Diabetic Macular Edema
NCT02874859 is registered in ClinicalTrials.gov with Lille Catholic University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aflibercept Injection for Treatment of Diabetic Macular Edema
- Lead sponsor
- Lille Catholic University
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 9, 2016
- Completion date
- August 19, 2020
- Enrollment
- 49 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema